Home

SNY

Genzyme Rejects Bid from Sanofi Aventis

By pennystockexplosion on Mon, 2010-08-30 16:00
(via www.pennystockexplosion.com)

This morning people woke up to shares of Genzyme Corp. (NASDAQ:GENZ) trading sharply higher in pre-market trading. On Sunday, Genzyme received an $18.5 billion offer from Sanofi-Aventis (NYSE:SNY) which comes to $69 per share.

Will Biotech Heat Up the Penny Stock World?

By pennystockexplosion on Fri, 2010-07-30 12:05
(via www.pennystockexplosion.com)

History tells us that a high profile takeover of a company like GENZ usually spurs interest within the particular sector. This interest also can trickle down from the NYSE to the OTCBB as speculative money is getting freed up with the turn in the markets.

A Lack of Logic Around China Sky One Medical (CSKI)

By MagicDiligence on Wed, 2010-07-07 12:16
(via www.magicdiligence.com)

China Sky One Medical (CSKI) features great growth prospects, a solid balance sheet, and a good industry. But fear has pushed the stock price to unfathomable depths. MagicDiligence uses research and logic to look into the primary arguments made against the company... and finds them deeply lacking.

Magic Formula Stock Review: Eli Lilly (LLY)

By MagicDiligence on Mon, 2010-06-28 08:17
(via www.magicdiligence.com)

Eli Lilly, a huge global pharmaceutical company, has a solid portfolio of drugs, a cheap stock price. and pays an attractive dividend. It also faces one of the largest patent cliffs in the industry and a recent important new drug has performed dismally in the market.